Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 170
Filter
1.
Br J Dermatol ; 176(5): 1259-1269, 2017 May.
Article in English | MEDLINE | ID: mdl-27679975

ABSTRACT

BACKGROUND: The method of generating bioengineered skin constructs was pioneered several decades ago; nowadays these constructs are used regularly for the treatment of severe burns and nonhealing wounds. Commonly, these constructs are comprised of skin fibroblasts within a collagen scaffold, forming the skin dermis, and stratified keratinocytes overlying this, forming the skin epidermis. In the past decade there has been a surge of interest in bioengineered skins, with researchers seeking alternative cell sources, or scaffolds, from which constructs can be established, and for more biomimetic equivalents with skin appendages. OBJECTIVES: To evaluate whether human hair follicle dermal cells can act as an alternative cell source for engineering the dermal component of engineered skin constructs. METHODS: We established in vitro skin constructs by incorporating into the collagenous dermal compartment: (i) primary interfollicular dermal fibroblasts, (ii) hair follicle dermal papilla cells or (iii) hair follicle dermal sheath cells. In vivo skins were established by mixing dermal cells and keratinocytes in chambers on top of immunologically compromised mice. RESULTS: All fibroblast subtypes were capable of supporting growth of overlying epithelial cells, both in vitro and in vivo. However, we found hair follicle dermal sheath cells to be superior to fibroblasts in their capacity to influence the establishment of a basal lamina. CONCLUSIONS: Human hair follicle dermal cells can be readily interchanged with interfollicular fibroblasts and used as an alternative cell source for establishing the dermal component of engineered skin both in vitro and in vivo.


Subject(s)
Hair Follicle/physiology , Skin, Artificial , Tissue Engineering , Basement Membrane/cytology , Cell Culture Techniques/methods , Cell Differentiation/physiology , Cell Proliferation/physiology , Fibroblasts/cytology , Fibroblasts/transplantation , Hair Follicle/cytology , Heterografts , Humans , Keratinocytes/cytology , Keratinocytes/transplantation , Microscopy, Electron, Transmission , Tissue Scaffolds , Transplantation, Heterologous
2.
Br J Cancer ; 113(6): 864-71, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26325106

ABSTRACT

BACKGROUND: Hypoxia is thought to be an adverse feature of pancreatic cancer, but direct measurement in patients is technically challenging. To address this, we characterised the intra/interpatient heterogeneity of hypoxia in surgical specimens from patients who received the 2-nitroimidazole tracer pimonidazole pre-operatively. METHODS: Pimondazole was given intravenously 16-20 h before pancreatectomy, and the extent and intratumoral heterogeneity of hypoxia determined by image analysis applied to multiple tissue blocks stained by immunohistochemistry. Intra/interpatient heterogeneity was estimated by variance component analysis. RESULTS: Pimonidazole staining was analysed in 10 tumours. The extent of labelling varied amongst patients (0-26%), with a broader range of hypoxia in the epithelial (1-39%) compared with the stromal (1-13%) compartments. Variance component analysis demonstrated greater inter- than intrapatient variability of hypoxia, and that multiple (4-5) tumour sections are required to provide a consistent evaluation of its extent in individual tumours. CONCLUSIONS: There is significant intra- and intertumoral heterogeneity of hypoxia in pancreatic cancers, and these do not appear to be generally more hypoxic than other cancer types. This study establishes the feasibility to assess hypoxia in pancreatic cancer patients using pimonidazole, but questions the reliability of measurements made using a single tissue section.


Subject(s)
Carcinoma, Pancreatic Ductal/metabolism , Cell Hypoxia , Indicators and Reagents/metabolism , Nitroimidazoles/metabolism , Pancreatic Neoplasms/metabolism , Adult , Analysis of Variance , Carcinoma, Pancreatic Ductal/pathology , Carcinoma, Pancreatic Ductal/surgery , Feasibility Studies , Female , Humans , Immunohistochemistry , Indicators and Reagents/administration & dosage , Injections, Intravenous , Male , Nitroimidazoles/administration & dosage , Pancreas/metabolism , Pancreatectomy , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/surgery , Premedication , Selection Bias
3.
Curr Mol Med ; 14(5): 565-79, 2014.
Article in English | MEDLINE | ID: mdl-24894165

ABSTRACT

Conditions of poor oxygenation (hypoxia) are present in the majority of solid human tumors and are associated with poor patient prognosis due to both hypoxia-mediated resistance to treatment, and to hypoxia induced biological changes that promote increased malignancy, including metastasis. Tumor cells respond to hypoxia by activating several oxygen-sensitive signaling pathways that include the hypoxia inducible factor 1/2 (HIF1/2) signalling pathways and the unfolded protein response (UPR), which alter gene expression to promote adaptation and survival during hypoxic conditions. Furthermore, these hypoxia responsive pathways can lead to changes in gene expression and cellular phenotype that influence the potential of cancer cells to metastasize. However, the hypoxia-induced signaling events that promote tumor metastasis are still relatively poorly understood. Previous studies have largely focused on the contribution of the HIF signaling pathway to hypoxia-mediated metastasis. However, recent evidence demonstrates that hypoxic activation of the UPR is also an important mediator of metastasis.


Subject(s)
Hypoxia/metabolism , Neoplasms/metabolism , Neoplasms/pathology , Signal Transduction/physiology , Animals , Humans , Hypoxia-Inducible Factor 1/metabolism , Models, Biological , Neoplasm Metastasis/genetics , Neoplasm Metastasis/physiopathology , Unfolded Protein Response/physiology
4.
Radiat Res ; 179(2): 125-34, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23237541

ABSTRACT

Exposure of civilian populations to radiation due to accident, war or terrorist act is an increasing concern. The lung is one of the more radiosensitive organs that may be affected in people receiving partial-body irradiation and radiation injury in lung is thought to be associated with the development of a prolonged inflammatory response. Here we examined how effectively damage to the lung can be mitigated by administration of drugs initiated at different times after radiation exposure and examined response in adolescent animals for comparison with the young adult animals that we had studied previously. We studied the mitigation efficacy of the isoflavone genistein (50 mg/kg) and the salen-Mn superoxide dismutase-catalase mimetic EUK-207 (8 mg/kg), both of which have been reported to scavenge reactive oxygen species and reduce activity of the NFkB pathway. The drugs were given by subcutaneous injection to 6- to 7-week-old Fisher rats daily starting either immediately or 2 weeks after irradiation with 12 Gy to the whole thorax. The treatment was stopped at 28 weeks post irradiation and the animals were assessed for levels of inflammatory cytokines, activated macrophages, oxidative damage and fibrosis at 48 weeks post irradiation. We demonstrated that both genistein and EUK-207 delayed and suppressed the increased breathing rate associated with pneumonitis. These agents also reduced levels of oxidative damage (50-100%), levels of TGF-ß1 expression (75-100%), activated macrophages (20-60%) and fibrosis (60-80%). The adolescent rats developed pneumonitis earlier following irradiation of the lung than did the adult rats leading to greater severe morbidity requiring euthanasia (∼37% in adolescents vs. ∼10% in young adults) but the extent of the mitigation of the damage was similar or slightly greater.


Subject(s)
Genistein/pharmacology , Lung Injury/drug therapy , Organometallic Compounds/pharmacology , Radiation Injuries, Experimental/drug therapy , Radiation-Protective Agents/pharmacology , Age Factors , Animals , Cytokines/metabolism , Female , Fibrosis , Genistein/therapeutic use , Lung/drug effects , Lung/pathology , Lung/physiopathology , Lung/radiation effects , Lung Injury/metabolism , Lung Injury/pathology , Lung Injury/physiopathology , Macrophages/drug effects , Macrophages/immunology , Macrophages/metabolism , Macrophages/radiation effects , Organometallic Compounds/therapeutic use , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Radiation Injuries, Experimental/metabolism , Radiation Injuries, Experimental/pathology , Radiation Injuries, Experimental/physiopathology , Radiation-Protective Agents/therapeutic use , Rats , Respiration/drug effects , Respiration/radiation effects
5.
Radiat Res ; 176(6): 770-80, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22013884

ABSTRACT

There is a serious need to develop effective mitigators against accidental radiation exposures. In radiation accidents, many people may receive nonuniform whole-body or partial-body irradiation. The lung is one of the more radiosensitive organs, demonstrating pneumonitis and fibrosis that are believed to develop at least partially because of radiation-induced chronic inflammation. Here we addressed the crucial questions of how damage to the lung can be mitigated and whether the response is affected by irradiation to the rest of the body. We examined the widely used dietary supplement genistein given at two dietary levels (750 or 3750 mg/kg) to Fischer rats irradiated with 12 Gy to the lung or 8 Gy to the lung + 4 Gy to the whole body excluding the head and tail (whole torso). We found that genistein had promising mitigating effects on oxidative damage, pneumonitis and fibrosis even at late times (36 weeks) when drug treatment was initiated 1 week after irradiation and stopped at 28 weeks postirradiation. The higher dose of genistein showed no greater beneficial effect. Combined lung and whole-torso irradiation caused more lung-related severe morbidity resulting in euthanasia of the animals than lung irradiation alone.


Subject(s)
Lung Injury/drug therapy , Radiation Injuries, Experimental/drug therapy , Radiation Injuries, Experimental/etiology , Radioactive Hazard Release , Animals , Cytokines/metabolism , Dietary Supplements , Female , Genistein/pharmacology , Genistein/therapeutic use , Lung Injury/metabolism , Lung Injury/physiopathology , Macrophages/drug effects , Macrophages/metabolism , Macrophages/radiation effects , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Pulmonary Fibrosis/drug therapy , Pulmonary Fibrosis/etiology , Radiation Injuries, Experimental/metabolism , Radiation Injuries, Experimental/physiopathology , Radiation-Protective Agents/pharmacology , Radiation-Protective Agents/therapeutic use , Rats , Rats, Inbred F344 , Respiration/drug effects , Respiration/radiation effects , Survival Analysis
6.
Med Phys ; 38(2): 845-56, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21452722

ABSTRACT

PURPOSE: To assess image quality and image-guidance capabilities of a cone-beam CT based small-animal image-guided irradiation unit (micro-IGRT). METHODS: A micro-IGRT system has been developed in collaboration with the authors' laboratory as a means to study the radiobiological effects of conformal radiation dose distributions in small animals. The system, the X-Rad 225Cx, consists of a 225 kVp x-ray tube and a flat-panel amorphous silicon detector mounted on a rotational C-arm gantry and is capable of both fluoroscopic x-ray and cone-beam CT imaging, as well as image-guided placement of the radiation beams. Image quality (voxel noise, modulation transfer, CT number accuracy, and geometric accuracy characteristics) was assessed using water cylinder and micro-CT test phantoms. Image guidance was tested by analyzing the dose delivered to radiochromic films fixed to BB's through the end-to-end process of imaging, targeting the center of the BB, and irradiation of the film/BB in order to compare the offset between the center of the field and the center of the BB. Image quality and geometric studies were repeated over a 5-7 month period to assess stability. RESULTS: CT numbers reported were found to be linear (R2 0.998) and the noise for images of homogeneous water phantom was 30 HU at imaging doses of approximately 1 cGy (to water). The presampled MTF at 50% and 10% reached 0.64 and 1.35 mm(-1), respectively. Targeting accuracy by means of film irradiations was shown to have a mean displacement error of [deltax, deltay, deltaz] = [-0.12, -0.05, -0.02] mm, with standard deviations of [0.02, 0.20, 0.17] mm. The system has proven to be stable over time, with both the image quality and image-guidance performance being reproducible for the duration of the studies. CONCLUSIONS: The micro-IGRT unit provides soft-tissue imaging of small-animal anatomy at acceptable imaging doses (< or =1 cGy). The geometric accuracy and targeting systems permit dose placement with submillimeter accuracy and precision. The system has proven itself to be stable over 2 yr of routine laboratory use (>1800 irradiations) and provides a platform for the exploration of targeted radiation effects in small-animal models.


Subject(s)
Cone-Beam Computed Tomography/methods , Radiotherapy/methods , Cone-Beam Computed Tomography/instrumentation , Laboratories , Mechanical Phenomena , Radiotherapy/instrumentation , Reproducibility of Results , Time Factors
7.
Radiat Res ; 172(1): 106-13, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19580512

ABSTRACT

In a previous study, we demonstrated DNA damage, expressed as micronuclei, in binucleate dermal fibroblasts obtained from human skin 2-9 weeks after fractionated radiotherapy. Here we assessed micronuclei in X-irradiated skin fibroblasts from 9-14-week-old female Lewis rats as a function of time after a single dose of radiation to determine the lifetime of such damage in the skin. After irradiation with 5, 10, 15 and 18 Gy, formation of micronuclei at 1 day or 2 months postirradiation increased up to about 10 Gy, with evidence for a plateau at higher doses. The time course of micronuclei present in the skin fibroblasts demonstrated a plateau region (approximately 20 days after 18 Gy and about 2 months after 10 Gy) before the number of micronuclei started to decline. Residual micronuclei were observed for more than 1 year after irradiation. Monomicronucleated cells predominated in fibroblasts from nonirradiated skin, whereas in fibroblasts from irradiated skin, multimicronucleated cells predominated and persisted (together with monomicronucleated cells) in the residual levels of damage at late times. The results suggest that DNA damage in dermal fibroblasts can be assayed by the micronucleus assay in samples from irradiated skin up to 1 month after irradiation for doses up to at least 10 Gy. Further studies are needed to define the dose-response relationship in detail.


Subject(s)
Fibroblasts/radiation effects , Micronuclei, Chromosome-Defective/radiation effects , Skin/radiation effects , Aging , Analysis of Variance , Animals , Dose-Response Relationship, Radiation , Female , Humans , Micronucleus Tests , Rats , Rats, Inbred Lew , Skin/cytology , Time Factors
8.
Oncogene ; 25(49): 6489-96, 2006 Oct 19.
Article in English | MEDLINE | ID: mdl-16702949

ABSTRACT

Identifying versatile inhibitors of metastasis that operate in multiple sites against distinct cancer cell types is important for designing novel therapeutics for metastasis. We show that multiple tissues of timp-3-/- mice are more susceptible to metastatic colonization. Overall, a 5-14-fold increase in liver and kidney colonization occurred by EL-4 lymphoma cells, and a twofold increase upon targeting B16F10 melanoma cells to the bone or lung of timp-3-/- mice. There was a general lack of macrophage or neutrophil localization to metastases in the liver, kidney and lung, and of osteoclasts to bone in both genotypes. Analysis of lung showed that proliferation or angiogenesis were unaltered within the metastatic colonies. Lung-trap assays revealed that initial tumor cell trapping was similar in the lung vasculature of timp-3-/- and wild-type mice. However, more tumor cells were found in timp-3-/- lungs at 48 and 96 h after tumor cell injection indicating more efficient extravasation and initial proliferation. Activation of pro-MMP-2 was greater in timp-3-/- lungs at these time points. These data demonstrate TIMP-3 functions to inhibit metastatic dissemination of diverse cancer cells to multiple organs. TIMP-3 regulates MMP-2 activation to limit tumor cell extravasation and subsequent colonization of the lung, without augmenting inflammatory cell response.


Subject(s)
Lymphoma/pathology , Melanoma, Experimental/secondary , Neoplasm Metastasis/genetics , Tissue Inhibitor of Metalloproteinase-3/genetics , Animals , Cell Proliferation , Genetic Predisposition to Disease , Inflammation/pathology , Kidney/pathology , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Lung/metabolism , Lung/pathology , Lung Neoplasms/pathology , Matrix Metalloproteinase 2/metabolism , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neoplasm Invasiveness/pathology , Neovascularization, Pathologic/mortality , Skin Neoplasms/pathology , Skin Neoplasms/secondary
9.
Ann Clin Biochem ; 43(Pt 1): 57-62, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16390610

ABSTRACT

BACKGROUND: Macroprolactin is a high molecular mass complex of prolactin that may be the cause of elevated serum prolactin as determined by immunoassay. The composition of macroprolactin and its reactivity in immunoassays are variable but the complex has minimal bioactivity in vivo. Hyperprolactinaemia due to unrecognized macroprolactinaemia can lead to misdiagnosis and mistreatment. METHODS: Serum from a patient with an unusual pattern of immunoreactivity was distributed to three users of each of the most popular immunoassays represented in the UK National External Quality Assessment Scheme (NEQAS) for prolactin. Clinical details were provided and participating centres were invited to investigate the prolactin content of the specimen according to their local protocol, and to comment on their results. The nature of the macroprolactin in the specimen was investigated in detail by gel filtration chromatography of the native serum and of the serum after adsorption of IgG with protein A, and by affinity chromatography with concanavalin A. RESULTS: Gel filtration studies revealed two peaks of macroprolactin in this serum. These macroprolactins were shown to be different in their IgG content and degree of glycosylation. All eight immunoassays reacted strongly with the macroprolactin present. The majority (78%) of centres that interpreted their results either demonstrated the presence of macroprolactin in the specimen, or suggested it as a likely cause of the hyperprolactinaemia. However, two centres inappropriately excluded macroprolactinaemia as the cause of the elevated prolactin, and a further two did not consider it at all. Data from previous UK NEQAS distributions (between 1996 and 2003) of macroprolactin containing sera are presented which suggest that the frequency of recognition of macroprolactin as a possible cause of hyperprolactinaemia has increased over time. CONCLUSIONS: Very high molecular mass forms of prolactin and the presence of multiple molecular mass forms, as detected in the case presented here, are uncommon. Also, the pattern of immunoreactivity reported in this specimen was unusual as most macroprolactins studied previously react less strongly in, for example, the Bayer ADVIA Centaur assay compared to the Roche E170 assay. Both peaks of macroprolactin in this serum reacted in all assays tested. This case highlights the variable nature and immunoreactive behaviour of macroprolactin species.


Subject(s)
Immunoassay/methods , Prolactin/blood , Prolactin/chemistry , Chromatography, Gel , Glycosylation , Humans , Immunoglobulin G/blood , Laboratories , Male , Middle Aged , Prolactin/immunology
10.
Peptides ; 27(2): 421-30, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16274855

ABSTRACT

Alpha-melanocyte stimulating hormone (alpha-MSH) has been identified as a potent anti-inflammatory in various tissues including the skin. It has previously been shown in skin cell keratinocytes and melanocytes/melanoma cells that MSH peptides inhibit TNF-alpha stimulated NF-kappaB activity and intercellular adhesion molecule-1 (ICAM-1) upregulation. However, the precise anti-inflammatory role of MSH peptides in dermal fibroblasts is unclear. Some studies report on pro-inflammatory responses, while others on anti-inflammatory responses. The present study confirms MC1R expression in cultured human dermal fibroblasts and reports that the MSH peptides alpha-MSH and KP(-D-)V inhibit TNF-alpha stimulated NF-kappaB activity and ICAM-1 upregulation, consistent with an anti-inflammatory role. However, involvement of IkappaB-alpha regulation by either peptide was not confirmed, supporting a mechanism independent of the NF-kappaB inhibitor. In conclusion, alpha-MSH and KP(-D-)V peptides have an anti-inflammatory action on dermal fibroblast signaling by inhibiting the pro-inflammatory activity of TNF-alpha in vitro.


Subject(s)
Dermis/cytology , Fibroblasts/cytology , Melanocyte-Stimulating Hormones/pharmacology , Peptides/pharmacology , Signal Transduction/physiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Cell Line, Tumor , Cells, Cultured , Fibroblasts/immunology , Humans , Intercellular Adhesion Molecule-1/metabolism , NF-kappa B/metabolism , Receptor, Melanocortin, Type 1/metabolism , Tumor Necrosis Factor-alpha/metabolism
11.
J Mater Sci Mater Med ; 15(7): 743-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15387408

ABSTRACT

The survival of grafted donor skin for the treatment of burn injuries depends on several factors including wound bed vascularisation and the intensity of acute inflammation shortly after injury. However, acceptance rates approximate 50% at best and therefore a clinical need exists for improvement. The aim of the study was to develop a method for assessing the inflammatory response of cells in skin tissue based on activation of the NF-kappa B (NF-kappaB) transcription factor complex, thereby providing a basis for analysing the inflammatory component and anti-inflammatory strategies for tissue-engineered treatments. We have extended a standard method of measuring NF-kappaB in monolayer cultures that relies on determining translocation of the p65 subunit from the cytoplasm to the nucleus. Normal human skin and tissue engineered skin was analysed using an immunofluorescence microscopy technique, that revealed base line NF-kappaB activation in the epidermis and dermis were different. It was possible to determine the activation of NF-kappaB in skin tissue, enabling correlation that NF-kappaB measurement is a sensitive indicator of cellular responses in 3-D tissue. The approach will provide a basis for early responses of skin cells in determining the efficacy of anti-inflammatory delivery via tissue-engineered scaffolds for burn injuries.


Subject(s)
NF-kappa B/metabolism , Skin/metabolism , Dermis/cytology , Dermis/metabolism , Fibroblasts/cytology , Fibroblasts/metabolism , Humans , Inflammation , Keratinocytes/cytology , Keratinocytes/metabolism , Kinetics , Plastic Surgery Procedures , Reference Values , Skin/cytology , Skin/physiopathology , Tissue Engineering/methods
12.
Br J Cancer ; 90(9): 1842-9, 2004 May 04.
Article in English | MEDLINE | ID: mdl-15150590

ABSTRACT

In addition to hypoxia, acidic extracellular pH (pH(e)) is recognised as one of the microenvironmental characteristics of solid tumours. A number of studies have examined ways to increase tumour acidity in order to improve tumour-specific targeting of certain drugs and the effectiveness of hyperthermia. However, previous data have shown that exposure of murine tumour cells to acid conditions in culture can enhance their metastatic potential when injected subsequently into mice, raising the concern that deliberate tumour acidification might increase the probability of metastasis. In this study, we examined the effects of in vivo tumour acidification and hypoxia on the spontaneous metastatic potential of the murine KHT-C fibrosarcoma and B16F1 melanoma cell lines. A tumour-specific increase in extracellular acidity, demonstrated by measurements with pH electrodes, was achieved by daily intraperitoneal injections of meta-iodo-benzylguanidine (MIBG) and/or glucose. This method of tumour acidification during tumour growth did not significantly enhance the spontaneous metastatic potential of the two murine cell lines.


Subject(s)
3-Iodobenzylguanidine/pharmacology , Fibrosarcoma/chemistry , Glucose/pharmacology , Melanoma, Experimental/chemistry , Neoplasm Metastasis/pathology , Animals , Cell Hypoxia/drug effects , Female , Fibrosarcoma/drug therapy , Hydrogen-Ion Concentration , Male , Melanoma, Experimental/drug therapy , Mice , Tumor Cells, Cultured
13.
Curr Mol Med ; 3(7): 659-71, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14601640

ABSTRACT

As tumors progress to increased malignancy, cells within them develop the ability to invade into surrounding normal tissues and through tissue boundaries to form new growths (metastases) at sites distinct from the primary tumor. The molecular mechanisms involved in this process are incompletely understood but those associated with cell-cell and cell-matrix adhesion, with the degradation of extracellular matrix, and with the initiation and maintenance of early growth at the new site are generally accepted to be critical. This article discusses current knowledge of molecular events involved in these various processes. The potential role of adhesion molecules (eg. integrins and cadherins) has undergone a major transition over the last ten years, as it has become apparent that such molecules play a major role in signaling from outside to inside a cell, thereby controlling how a cell is able (or not) to sense and interact with its local environment. Similarly the roles of proteolytic enzymes and their inhibitors (eg. matrix metalloproteinases and TIMPs) have also expanded as it has become apparent that they not only have the abilities to break down the components of the extracellular matrix but also are involved in the release of factors which can affect the growth of the tumor cells positively or negatively. Recent work has highlighted the importance of the later, post-extravasational stages of metastasis, where adhesion and proteolysis are now known to play a role along with other processes such as apoptosis, dormancy, growth factor-receptor interactions and signal transduction. Recent work has also demonstrated that not only the immediate cellular microenvironment, in terms of specific cell-cell and cell-matrix interactions, but also the extended cellular microenvironment, in terms of vascular insufficiency and hypoxia in the primary tumor, can modify cellular gene expression and enhance metastasis. Mechanisms of metastasis appear to involve a complex array of genetic and epigenetic changes many of which appear to be specific both for different types of tumors and for different sites of metastasis. Our improved understanding of the expanded roles of the individual molecules involved has resulted in a mechanistic blurring of the previously described discrete stages of the metastatic process.


Subject(s)
Neoplasm Invasiveness , Neoplasm Metastasis , Animals , Apoptosis/physiology , Cell Adhesion/physiology , Humans , Metalloproteases/metabolism
14.
Int J Radiat Biol ; 79(7): 487-94, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14530156

ABSTRACT

Long overall treatment times are detrimental for cure by radiotherapy and it has been argued that this may be due to repopulation occurring during the course of treatment. However, attempts to predict treatment outcome in relation to tumour proliferation, using pretreatment measurements of kinetic parameters such as Tpot or labelling index (LI) have not met with great success. One possible reason is that hypoxia/reoxygenation is linked to the growth of the tumour and its ability to repopulate. Data from studies in animal models have provided support for this possibility. We made measurement of tumour hypoxia, reoxygenation during treatment and pretreatment measurements of both Tpot and LI in groups of patients with cervix carcinoma undergoing radical radiation treatment. The data show a relationship between pretreatment pO2 measurements and treatment outcome, but reoxygenation did not show any association with treatment outcome. There was no significant association between pretreatment kinetic parameters and treatment outcome, nor was there any evidence of a relationship between pretreatment kinetic parameters and pO2. In the small group of 28 patients whose tumours underwent measurements of both pretreatment kinetic parameters (Tpot, LI) and reoxygenation, there was no relationship between these two sets of measurements. There was also no evidence that a combination of kinetic and reoxygenation measurements could be predictive of treatment outcome.


Subject(s)
Cell Hypoxia/physiology , Oxygen/metabolism , Uterine Cervical Neoplasms/radiotherapy , Animals , Brachytherapy , Cell Division/radiation effects , Dose Fractionation, Radiation , Female , Humans , Mice , Neoplasm Recurrence, Local , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/pathology
15.
J Clin Oncol ; 20(3): 680-7, 2002 Feb 01.
Article in English | MEDLINE | ID: mdl-11821448

ABSTRACT

PURPOSE: This prospective clinical study was begun in 1994 to validate the independent prognostic impact of tumor hypoxia in patients with cervix cancer treated with definitive radiation therapy. PATIENTS AND METHODS: Between May 1994 and January 1999, 106 eligible patients with epithelial cervix cancer had tumor oxygen pressure (PO(2)) measured using the Eppendorf probe. Oxygenation data are presented as the hypoxic proportion, defined as the percentage of PO(2) readings less than 5 mm/Hg (abbreviated as HP(5)) and the median PO(2). RESULTS: The median HP(5) in individual patients was 48%, and the median PO(2) was HP(5). Progression-free survival (PFS) for patients with hypoxic tumors (HP(5) > 50%) was 37% at 3 years versus 67% in those patients with better oxygenated tumors (P =.004). In multivariate analysis, only tumor size (risk ratio [RR], 1.33; P =.0003) and evidence of pelvic nodal metastases on imaging studies (RR, 2.52; P =.0065) were predictive of PFS. However, an interaction between nodal status and oxygenation was observed (P =.006), and further analysis indicated that HP(5) was an independent predictor of outcome in patients with negative nodes on imaging (P =.007). There was a significant increase in the 3-year cumulative incidence of distant metastases in the hypoxic group (41% v 15% in those with HP(5) < 50%; P =.0023), but not in pelvic relapse (37% v 27%; P =.12). CONCLUSION: Tumor hypoxia is an independent predictor of poor PFS only in patients with node-negative cervix cancer, in addition to tumor size. Its impact appears to be related to an increased risk of distant metastases rather than to an effect on pelvic control.


Subject(s)
Cell Hypoxia/physiology , Lymph Nodes/pathology , Uterine Cervical Neoplasms/physiopathology , Female , Humans , Lymphatic Metastasis , Prognosis , Prospective Studies , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/radiotherapy
16.
Novartis Found Symp ; 240: 154-65; discussion 165-8, 2001.
Article in English | MEDLINE | ID: mdl-11727927

ABSTRACT

The vascular supply to tumours is often poorly formed and irregular with the result that tumours may contain regions of poor nutritional supply with hypoxia and acidic pH. Clinical studies have demonstrated substantial heterogeneity in oxygenation in human tumours. In some studies tumours with poorer oxygenation were more likely to have metastasized. In our studies of carcinoma of the cervix, nodal metastases were 1.5 times more likely at diagnosis in patients with more hypoxic tumours relative to those with less hypoxic tumours. Transplanted rodent KHT fibrosarcomas and SCC-VII squamous cell tumours also have variability in levels of oxygenation; again, the more hypoxic tumours are found to be more metastatic. Furthermore, deliberate exposure of KHT tumours to cyclic hypoxia (12 cycles of 5% oxygen breathing for 10 min interspersed with 10 min air breathing) every day during their growth, doubled the level of micrometastases that were detected in the lungs of the mice. These findings are consistent with in vitro studies demonstrating that KHT and SCC-VII cells and B-16 melanoma cells exposed to hypoxia or low pH have increased propensity to form metastases following injection into-mice. This effect is transient and is lost within about 48 h of removal of exposure to hypoxia or low pH, suggesting that the effect may be due to changes in gene expression associated with that stress. Recent studies have implicated a number of genes, such as vascular endothelial growth factor and interleukin 8, in the effect of hypoxic and acid pH on metastasis.


Subject(s)
Cell Hypoxia , Hydrogen-Ion Concentration , Neoplasm Metastasis , Aerobiosis , Extracellular Space/physiology , Humans , Neoplasms/metabolism , Neoplasms/pathology , Prognosis
17.
Cancer Res ; 61(24): 8903-8, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11751415

ABSTRACT

Hypoxia exists in most human and rodent solid tumors and has been shown to correlate with poor survival in carcinoma of the cervix, carcinoma of the head and neck, and soft tissue sarcoma. It exists both chronically, due to the poorly organized vasculature of solid tumors, and acutely, due to fluctuations in blood flow. It has been found that tumors that are more hypoxic are more likely to metastasize in humans and in rodent models, and it has been demonstrated that exposure of tumor cells to hypoxia in vitro can transiently enhance their metastatic potential when they are reinjected i.v. into mice. The purpose of the present study was to determine whether experimentally imposed hypoxic stress in vivo, either chronic or acute, affects the process of spontaneous metastasis in tumor-bearing mice. We exposed mice bearing KHT tumors to low oxygen conditions (5-7% O(2) breathing) daily during tumor growth in an attempt to induce additional chronic (2 h/day) and acute (12 x 10 min/day) hypoxia in their tumors. By monitoring tumor pO(2) levels over the course of treatment, we demonstrated that these treatments produce acute and chronic hypoxia within the tumor tissue. The acute but not the chronic hypoxia treatment significantly increased the number of spontaneous microscopic lung metastases in the mice by a factor of about 2, and the results suggest that this effect was due to the changes induced in the primary tumor. This study describes a novel method for studying the effects of hypoxia in solid tumors and demonstrates that acute and chronic hypoxia can have different effects on tumor cell behavior in vivo.


Subject(s)
Fibrosarcoma/metabolism , Fibrosarcoma/secondary , Lung Neoplasms/metabolism , Lung Neoplasms/secondary , Neoplasms, Experimental/metabolism , Neoplasms, Experimental/pathology , Oxygen/metabolism , Animals , Cell Hypoxia/physiology , Fibrosarcoma/pathology , Lung Neoplasms/pathology , Male , Mice , Mice, Inbred C3H , Partial Pressure
18.
Br J Cancer ; 84(9): 1280-5, 2001 May 04.
Article in English | MEDLINE | ID: mdl-11336482

ABSTRACT

The relationship between tumour oxygenation in vivo and metastatic potential was investigated in 2 rodent tumour models, KHT-C fibrosarcoma and SCC-VII squamous cell carcinoma. The oxygen status in these rodent tumours transplanted intramuscularly in syngeneic mice was measured using the Eppendorf pO(2)Histograph. The results indicate a considerable heterogeneity in oxygenation between individual tumours within each tumour cell line. At different tumour sizes, animals were killed and lung lobes were examined for macroscopic and microscopic lung metastases. In the KHT-C tumours, a significant increase in early pulmonary metastasis formation was observed in mice with hypoxic primary tumours. Hypoxic SCC-VII tumours did not give rise to enhanced lung metastasis formation despite oxygenation in a range similar to the KHT-C tumours. However, the overall metastasis incidence in the SCC-VII model was very low. The results obtained in the KHT-C model, which show that hypoxic tumours are more likely to metastasize, are in agreement with recent clinical data suggesting that a hypoxic environment might be implicated in metastatic ability of human tumours.


Subject(s)
Carcinoma, Squamous Cell/pathology , Fibrosarcoma/pathology , Hypoxia , Lung Neoplasms/secondary , Animals , Mice , Risk Factors , Tumor Cells, Cultured
19.
Int J Radiat Oncol Biol Phys ; 49(2): 353-65, 2001 Feb 01.
Article in English | MEDLINE | ID: mdl-11173128

ABSTRACT

This manuscript is in four parts, presenting the four talks given in a symposium on normal tissue radiobiology. The first part addresses the general concept of the role of parenchymal cell radiosensitivity vs. other factors, highlighting research over the last decade that has altered our understanding of factors underlying normal tissue response. The other three parts expand on specific themes raised in the first part dealing in particular with (1) modifications of fibroblast response to irradiation in relation to the induction of tissue fibrosis, (2) the use of the linear-quadratic equation to model the potential benefits of using different means (both physical and biologic) of modifying normal tissue response, and (3) the specific role of the growth factor TFG-beta1 in normal tissue response to irradiation. The symposium highlights the complexities of the radiobiology of late normal tissue responses, yet provides evidence and ideas about how the clinical problem of such responses may be modified or alleviated.


Subject(s)
Diffusion of Innovation , Radiation Tolerance/physiology , Radiobiology , Transforming Growth Factor beta/physiology , Animals , Ataxia Telangiectasia/radiotherapy , Cell Differentiation , Cell Survival , Cytokines/metabolism , Dose Fractionation, Radiation , Dose-Response Relationship, Radiation , Fibroblasts/physiology , Fibroblasts/radiation effects , Fibrosis/etiology , Humans , Linear Models , Lung/metabolism , Lung/radiation effects , Mice , Mice, SCID , Models, Biological , Organ Specificity , Radiation Injuries/etiology , Radiation Injuries/metabolism , Radiation Injuries/pathology , Radiation Injuries/prevention & control , Rats , Relative Biological Effectiveness , Transforming Growth Factor beta/antagonists & inhibitors , Transforming Growth Factor beta1 , Treatment Outcome , Up-Regulation
20.
Int J Radiat Oncol Biol Phys ; 48(5): 1539-48, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11121660

ABSTRACT

PURPOSE: Recent observations have shown that there are regional variations in radiation response in mouse lung as measured by functional assays. Furthermore, there are both in-field and out-of-field effects in radiation-induced lung damage as observed by DNA assay in rats. The purpose of this work is: (a) to examine mice lethality data following partial volume lung irradiation to assess the possibility of directional or regional effects, (b) to evaluate the correlation between mice lethality data and DNA damage assayed by micronuclei production in rat lung, and (c) to re-interpret mice lethality considering the existence of directional effects in lung cellular response to partial volume irradiation. METHODS AND MATERIALS: The lethality data for mice, generated at the M. D. Anderson Cancer Center, Houston, and micronuclei yield data for rats obtained at Princess Margaret Hospital, Toronto, were used. A radiobiological model that allows for out-of-field and in-field effects for lung cell damage and lung response was developed. This model is based on the observation of DNA damage in shielded parts of rat lung that was assumed relevant to cell lethality and consequently overall lung response. RESULTS: While the experimental data indicated directional or regional volume effects, the applicability of dose and volume as sole predictors of lung response to radiation was found to be unreliable for lower lung (base) irradiation in mice. This conforms well to rat lung response where micronuclei were observed in shielded apical parts of lung following base irradiation. The radiobiological model, which was specifically developed to account for the lung response outside of primary irradiated volume, provides a good fit to mice lethality data, using parameters inferred from rat micronuclei data. CONCLUSION: Response to lung irradiation in rodents, in particular, elevated sensitivity to base irradiation, can be interpreted with a hypothesis of in-field and out-of-field effects for cellular response. If the existence of these effects for lung is subsequently proven in humans, it will require the incorporation of geometrical and directional information in normal tissue complication probability calculations for lung. These considerations are ignored in present approaches based only on conventional dose-volume histograms.


Subject(s)
DNA Damage , Lung/radiation effects , Micronuclei, Chromosome-Defective/radiation effects , Models, Biological , Radiation Pneumonitis/pathology , Animals , Likelihood Functions , Lung/pathology , Lung/ultrastructure , Mice , Radiation Pneumonitis/etiology , Radiation Protection , Radiobiology
SELECTION OF CITATIONS
SEARCH DETAIL
...